AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2010
Sep 22, 2010
35124_dirs_2010-09-22_29dc6f55-178d-47f4-b7d1-50aa5d50a28d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2010-09-22
Reporting Person: Borys Nicholas (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-09-22 | Celsion Corporation Common Stock | P | 1550 | $3.03 | Acquired | 28087 | Direct |
| 2010-09-22 | Celsion Corporation Common Stock | P | 100 | $3.04 | Acquired | 28187 | Direct |
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18